Skip to the page content
Your donations
Passes our checks

Society for Translational Oncology Inc

EIN 20-3186261 · Durham, NC

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthWeak48 out of 100GovernanceGood83 out of 100Impact evidenceDescribes programsHow well its results are evidenced

Points to look into

  • Only 40% of its spending went to programs.

These come from the organization's own tax return. There may be a good explanation; ask the charity.

What it says it does

See Schedule O

Income
$289,410
Spending
$536,505
Spent on programs
40%
Reserves
7 months of spending
Largest source of income
donations and private grants, 57%
Employees
4
Volunteers
32

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Weak: 48 out of 100. Higher than 8% of charities in its peer group (medical research, $250k to $1m).

  • Reserves

    28 of 35

    Spendable reserves would cover 7.0 months of spending.

  • Debt

    20 of 20

    It owes 5% of what it owns.

  • Living within its means

    0 of 15

    Spending exceeded income by 85% of income.

  • Income trend

    0 of 15

    Income fell 39% on the year before.

  • Spending floor

    0 of 15

    40% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Good: 83 out of 100. Higher than 64% of charities in its peer group (medical research, $250k to $1m).

  • Independent board

    25 of 25

    7 of 7 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    0 of 7

    Reports no written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (3)
  1. $87,207 spent. HARMONY is a global initiative advancing equitable cancer care by improving alignment across clinical research, regulatory pathways and implementation. In response to persistent disparities in access to cancer prevention, screening and treatment, HARMONY convenes international stakeholders to reduce fragmentation, strengthen collaboration and accelerate the translation of evidence into practice. Current activities focus on cervical cancer, a largely preventable disease that causes disproportionate mortality in low-resource and underserved settings. HARMONY supports harmonized approaches to clinical trials and implementation research, promotes equitable access to evidence-based interventions (HPV screening and early detection), and builds collaborative networks to advance sustainable, scalable solutions. Collectively, these efforts aim to ensure that innovations in cervical cancer prevention and care reach populations most at risk and contribute to global elimination goals.
  2. $38,818 spent. Molecular testing is a foundational element of personalized medicine. Understanding and overcoming challenges in implementing best practice guidelines for molecular testing can support better diagnosis and guide treatment decisions. "Incorporating Molecular Testing to Support Personalized Cancer Care" is a three-part educational program that focuses on the adoption of best practice guidelines and incorporating evidence from an MD Anderson Cancer Network Performance Improvement and Quality Improvement (PI/QI) program (a program of The University of Texas MD Anderson Cancer Center). Piloted at two Cancer Network sites, this PI/QI program aimed to optimize the use of molecular testing in thyroid and lung cancers.
  3. $86,312 spent. The Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization that promotes high-quality, equitable patient care and fosters the discovery and clinical translation of important new therapies that enhance the practice of global oncology as well as supports the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems, thus helping protect the vulnerable from life-threatening infections. STO bridges a translational gap between drug discovery and approved drug delivery with a portfolio of educational activities for physicians and other members of the healthcare team. STO's decades-long commitment to translational research and education includes fellowships in both cancer and infectious diseases. The latter has become a critical STO commitment during the COVID-19 pandemic from the global genesis to worldwide distribution of new vaccines and improved therapeutics. STO is committed to diversity, inclusivity, and equity throughout our programs.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since April 2009.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.